270076-04-5

Upstream product

• 676-58-4 methylmagnesium chloride 
• 270076-03-4 1,2-O-isopropylidene-α-D-erythro-pentofuranose-3-ulose 5-dibenzylphosphate 
• 538-37-4 dibenzyl phosphochloridate 
• 270076-02-3 5-O-dibenzylphosphono-1,2-O,O-isopropylidene-α-D-xylofuranose 

Downstream Products

• 270076-05-6 3-O-benzyl-1,2-O-isopropylidene-3-C-methyl-α-D-ribofuranose 5-dibenzylphosphate 
• 270076-08-9 2-O-benzyl-2-C-methyl-D-erythritol 4-dibenzylphosphate 
• 270076-07-8 2-O-benzyl-2-C-methyl-D-erythrose 4-dibenzylphosphate 
• 206440-72-4 2-C-methyl-D-erythritol 4-phosphate 

Relevant academic research and scientific papers

Expression and Characterization of Soluble 4-Diphosphocytidyl-2-C-methyl-D-erythritol Kinase from Bacterial Pathogens

Many bacterial pathogens utilize the 2-C-methyl-D-erythritol 4-phosphate pathway for biosynthesizing isoprenoid precursors, a pathway that is vital for bacterial survival and absent from human cells, providing a potential source of drug targets. However,

Chemical synthesis of enantiopure 2-C-methyl-D-erythritol 4-phosphate, the key intermediate in the mevalonate-independent pathway for isoprenoid biosynthesis

Optically pure 2-C-methyl-D-erythritol 4-phosphate, a key intermediate in the mevalonate-independent route for isoprenoid biosynthesis, is conveniently synthesized from 1,2-O-isopropylidene-α-D-xylofuranose, including the possibility of radiolabeling of t